期刊文献+

西罗莫司对膀胱癌BIU-87细胞增殖及侵袭能力的影响

Sirolimus inhibits proliferation and invasion of human bladder carcinoma cell line BIU-87
原文传递
导出
摘要 目的探讨西罗莫司对膀胱癌BIU-87细胞增殖和侵袭能力的作用。方法将BIU-87细胞贴壁培养于10%胎牛血清、100 U/ml青霉素、100μg/ml链霉素的RPMI-1640培养液中,37℃、5%CO饱和湿度培养箱中2培养。取对数生长的BIU-87细胞,处理组加入西罗莫司的浓度范围是(10-1000)nmol/L;对照组不加药物,每天紧更换1640培养液。MTT法分析各浓度组的生长抑制率并制作抑制曲线,Transwell法通过使用matrigel基质胶检测BIU-87细胞在体外的侵袭能力。结果西罗莫司对BIU-87细胞有明显抑制作用,呈时间和量效依赖关系。Transwell法发现不同浓度的西罗莫司可以减弱BIU-87细胞的体外侵袭能力,呈量效依赖性。结论西罗莫司可以抑制膀胱癌BIU-87细胞的增殖活性及侵袭能力。 Objective To study the effects of Sirolimus on proliferation and invasion of human bladder cancer BIU-87 cells. Methods BIU-87 cells were cultured in RPMI-1640 containing 10% fetal bovine serum and penicillin/streptomycin at 37℃ in a 5% CO2 incubator. BIU-87 cells of logarithmic growth phase were used and treated with various concentrations of Sirolimus solntion(10-1000nmol/L), cells in control group were only treated with RPMI-1640. The growth inhibition rate of BIU-87 cells was measured by MTT method, the invasion rate of BIU-87 cells was measured by Transwell chamber assay. Results Sirolimus inhibited the proliferation of BIU-87 cells in time and dose-dependent manners. Sirolimus inhibited the of BIU-87 cells by Transwell chamber assay. Conclusion Sirolimus inhibited the growth and invasiveness of BIU-87 bladder carcinoma cells.
出处 《解剖科学进展》 CAS 2014年第5期440-442,共3页 Progress of Anatomical Sciences
关键词 西罗莫司 BIU-87细胞 增殖 侵袭 sirolimus BIU-87 cell proliferation invasion
  • 相关文献

参考文献9

  • 1Zhang Q,Qiu JP,Kirtane AJ,et al.Comparison of biodegradable polymer versus durable polymer sirolimus-eluting stenting in patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention:results of the resolve study[J].J Interv Cardiol,2014,27(2):131-141.
  • 2Fidan K,Kandur Y,Sozen H,et al.How often do we face side effects of sirolimus in pediatric renal transplantation[J].Transplant Proc,2013,45(1):185-189.
  • 3Kai L,Wang Z,Yao W,et al.Sirolimus,a promising treatment for refractory Kaposiform hemangioendothelioma[J].J Cancer Res Clin Oncol,2014,140(3):471-476.
  • 4Mackay HJ,Eisenhauer EA,Kamel-Reid S,et al.Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer[J].Cancer,2014,120(4):603-610.
  • 5Kim SJ,Seo HK,Seo HH,et al.Establishment of an orthotopic mouse non-muscle invasive bladder cancer model expressing the Mammalian target of rapamycin signaling pathway[J].J Korean Med Sci,2014,29(3):343-350.
  • 6Li D,Li X,Cao W,et al.Antagonism of microRNA-99a promotes cell invasion and down-regulates E-cadherin expression in pancreatic cancer cells by regulating mammalian target of rapamycin[J].Acta Histochem,2014,S0065-1281(13):246-248.
  • 7Guilbert C,Annis MG,Dong Z,et al.Arsenic trioxide overcomes rapamycin-induced feedback activation of AKT and ERK signaling to enhance the anti-tumor effects in breast cancer[J].PLoS One,2013,8(12):e85995.
  • 8Liu WN,Lin JH,Cheng YR,et al.FIM-A,a phosphorus-containing sirolimus,inhibits the angiogenesis and proliferation of osteosarcomas[J].Oncol Res,2013,20(7):319-326.
  • 9Muilenburg D,Parsons C,Coates J,et al.Role of autophagy in apoptotic regulation by Akt in pancreatic cancer[J].Anticancer Res,2014,34(2):631-637.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部